#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	244	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1020	12.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	271	273	ACG	11;12;11	A;C;G	11;12;11	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	T879G	SNP	879	879	T	24	24	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	G880A	SNP	880	880	G	25	25	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	A888G	SNP	888	888	A	33	33	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	C897G	SNP	897	897	C	42	42	G	5	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	T898C	SNP	898	898	T	43	43	C	6	C	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	G906T	SNP	906	906	G	51	51	T	8	T	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	G908A	SNP	908	908	G	53	53	A	8	A	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	A918T	SNP	918	918	A	63	63	T	9	T	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	A943G	SNP	943	943	A	88	88	G	23	G	23	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	122	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	149	10.5	0	.	n	.	0	G991T	SNP	991	991	G	136	136	T	15	T	15	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	774	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c4.ctg.1	1398	26.4	1	SNP	p	R234F	1	.	.	700	702	TTC	888	890	TTC	33;33;33	T;T;C	33;33;33	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	774	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c4.ctg.1	1398	26.4	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1188	1190	CGT	31;31;32	C;G;T	31;31;32	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	774	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c4.ctg.1	1398	26.4	0	HET	.	.	.	T180C	.	180	180	T	368	368	T	18	T,C	8,8	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	774	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c4.ctg.2	280	6.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	354	Escherichia_coli_mutant_1	1359	214	99.53	Escherichia_coli_mutant_1.l6.c4.ctg.1	380	6.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	197	199	AAA	5;5;5	A;A;A	5;5;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	513	354	Escherichia_coli_mutant_1	1359	1164	99.74	Escherichia_coli_mutant_1.l6.c4.ctg.2	1332	12.1	0	.	p	.	0	F387L	NONSYN	1159	1161	TTT	1323	1325	CTT	2;2;2	C;T;T	0;1;2	.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	428	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1581	14.1	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1158	1160	GAA	19;19;19	G,C;A;A	18,1;19;19	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	126	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	709	8.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	54	G	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	52	C	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	54	C	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	53	T	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	73	C	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	46	C	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	47	A	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	44	A	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	44	A	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	38	T	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	38	C	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	37	C	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	37	A	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	30	G,A	29,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	37	T	37	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	47	G	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	49	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	47	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	58	T	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	57	G	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	42	C	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	39	A	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	30	C	30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	27	C	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	5	G	5	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	13	C	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	38	T	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	40	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	24	T	24	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c4.ctg.2	624	41.9	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	73	C	72	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	A303G	SNP	303	303	A	10	10	G	23	G,C	21,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	G375A	SNP	375	375	G	82	82	A	31	A	31	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	G383C	SNP	383	383	G	90	90	C	15	C	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	G385C	SNP	385	385	G	92	92	C	13	C	13	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	C388G	SNP	388	388	C	95	95	G	9	G	8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	544	1146	Pasteurella_multocida_16S	1551	104	94.23	Pasteurella_multocida_16S.l15.c4.ctg.5	104	46.7	0	.	n	.	0	C394T	SNP	394	394	C	101	101	T	2	T	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	276	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1107	11.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	9	11	CGT	8;8;8	C;G;T	1;1;1	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	276	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1107	11.7	0	.	p	.	0	H173Q	NONSYN	517	519	CAC	522	524	CAG	8;8;8	C;A;G,C	8;8;0,8	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	276	PmrB_1	1092	1092	99.18	PmrB_1.l6.c30.ctg.1	1107	11.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	852	854	GGC	10;10;10	G;G;C	10;10;10	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	398	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1826	11.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	28	30	AGC	7;7;7	A;G;C	7;7;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	398	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1826	11.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	430	432	CTA	7;7;6	C;T;A	7;7;6	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	398	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1826	11.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	949	951	CAA	19;19;18	C;A;A	19;19;18	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	398	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1826	11.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1048	1050	GGT	14;13;15	G;G;T	14;13;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	398	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1826	11.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1618	1620	GTT	7;7;7	G;T;T	7;7;7	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	769	194	PmrE	1167	945	97.47	PmrE.l6.c30.ctg.1	1102	8.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	532	534	GAA	13;13;13	G;A;A	13;13;13	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	769	194	PmrE	1167	945	97.47	PmrE.l6.c30.ctg.1	1102	8.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	712	714	ACC	3;3;3	A;C;C	2;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	769	194	PmrE	1167	192	97.92	PmrE.l6.c30.ctg.2	203	4.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	88	90	ATC	7;7;7	A;T;C	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	262	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1277	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	515	708	acrD	3114	85	97.65	acrD.l6.c30.ctg.1	215	5.6	0	.	p	.	0	I27L	NONSYN	79	81	ATT	209	211	CTT	1;1;1	C,A;T;T	0,1;1;1	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	515	708	acrD	3114	3082	99.09	acrD.l6.c30.ctg.2	3207	11.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	227	229	ATC	14;14;14	A;T;C	13;14;14	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	515	708	acrD	3114	3082	99.09	acrD.l6.c30.ctg.2	3207	11.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	1940	1942	AAG	3;4;3	A;A;G	3;4;3	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	258	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1275	10.5	0	.	p	.	0	A22V	NONSYN	64	66	GCC	130	132	GTC	2;2;2	G;T;C	2;2;2	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	258	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1275	10.5	0	.	p	.	0	S269C	NONSYN	805	807	AGC	871	873	TGC	12;12;12	T;G;C	12;12;12	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	155	155	T	5	T	5	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	461	463	GAC	13;13;13	G;A;C	13;13;13	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	737	739	TTA	3;3;3	T;T;A	3;3;3	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1814	1816	AAT	11;11;11	A;A;T	11;11;11	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1928	1930	AGT	8;8;8	A;G;T	8;8;8	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2327	2329	GTG	8;8;7	G;T;G	8;7;7	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	730	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3356	11.4	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2882	2884	AAG	11;11;10	A;A;G	11;11;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	188	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	863	10.5	1	SNP	p	R45C	0	.	.	133	135	CGC	215	217	CGC	14;14;14	C;G;C	14;14;14	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	172	acrS	663	663	98.79	acrS.l15.c30.ctg.1	740	11.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	139	141	TTC	10;10;9	T;T;C	10;10;9	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	172	acrS	663	663	98.79	acrS.l15.c30.ctg.1	740	11.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	403	405	GGG	11;11;11	G;G;G	11;11;11	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	198	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1113	9.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	587	589	CTT	15;14;14	C;T;T	15;14;14	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	780	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3022	13.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2092	2094	GCA	23;22;22	G;C;A	22;22;21	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	780	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3022	13.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2353	2355	ACC	18;18;18	A;C;C	18;17;18	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	780	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3022	13.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2662	2664	GCC	14;14;12	G;C;C	14;14;12	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	326	arnA_1	1983	1671	98.56	arnA_1.l6.c4.ctg.1	1705	9.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	138	140	GTT	5;6;8	G;T;T	5;5;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	326	arnA_1	1983	1671	98.56	arnA_1.l6.c4.ctg.1	1705	9.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	288	290	CAC	6;6;6	C;A;C	6;6;6	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	326	arnA_1	1983	1671	98.56	arnA_1.l6.c4.ctg.1	1705	9.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	573	575	ATG	12;12;12	A;T;G	11;10;11	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	326	arnA_1	1983	1671	98.56	arnA_1.l6.c4.ctg.1	1705	9.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1569	1571	CGC	7;7;8	C;G;C	7;6;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	326	arnA_1	1983	115	98.26	arnA_1.l6.c4.ctg.2	116	7.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	3	5	GCT	2;2;2	G;C;T	2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	182	bacA	822	822	98.54	bacA.l15.c4.ctg.1	956	9.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	775	777	ACC	6;6;6	A;C;C	6;6;6	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	182	bacA	822	822	98.54	bacA.l15.c4.ctg.1	956	9.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	787	789	TCG	3;3;3	T;C;G	3;3;3	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	539	136	baeR	723	723	97.65	baeR.l6.c30.ctg.1	992	7.2	0	.	p	.	0	S214F	NONSYN	640	642	TCT	859	861	TTT	1;1;1	T;T;T	1;1;1	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	308	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1570	10.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1214	1216	AAA	10;10;10	A;A;A	9;10;10	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	308	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1570	10.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1226	1228	GAG	7;7;7	G,C;A;G	6,1;7;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	308	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1570	10.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1232	1234	CAC	6;6;6	C;A;C	5;5;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	308	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1570	10.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1286	1288	GAG	6;6;6	G;A;G	6;6;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	406	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	1563	13.0	0	.	p	.	0	A231T	NONSYN	691	693	GCG	717	719	ACG	13;12;12	A;C;G	13;12;12	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	216	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	802	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	264	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1251	11.1	0	.	p	.	0	T132I	NONSYN	394	396	ACA	596	598	ATA	7;7;8	A;T;A	7;7;8	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	272	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1369	10.3	0	.	p	.	0	I219V	NONSYN	655	657	ATC	843	845	GTC	15;15;15	G;T;C	15;14;15	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	454	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	1876	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	324	emrD	1191	1191	98.57	emrD.l6.c4.ctg.1	1399	11.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	785	787	AGC	9;9;8	A;G;C	9;9;8	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	222	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1187	9.3	0	.	p	.	0	K176R	NONSYN	526	528	AAG	635	637	AGG	13;13;13	A;G;G	13;13;13	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	222	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1187	9.3	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1025	1027	GAC	10;10;10	G;A;C	10;10;10	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	154	emrR	531	531	100.0	emrR.l6.c4.ctg.1	867	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	402	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1885	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	134	evgA	615	615	99.17	evgA.l6.c4.ctg.1	782	8.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	173	175	CTG	6;5;5	C;T;G	6;5;5	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	180	182	AAA	8;9;10	A;A;A	8;9;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	915	917	CAT	5;5;4	C;A;T	5;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	969	971	CAT	8;8;8	C;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	987	989	AGA	7;8;7	A;G;A	7;8;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1002	1004	AAT	5;5;5	A;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1149	1151	TCC	3;4;4	T;C;C	3;4;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1314	1316	ATT	10;10;10	A;T;T	10;10;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1335	1337	GAT	5;5;5	G;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1449	1451	GTT	13;12;12	G;T,C;T	12;10,1;10	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	2477	97.9	evgS.l6.c30.ctg.1	2647	12.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1734	1736	CAC	8;8;8	C;A;C	8;7;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	102	104	ATA	6;6;6	A;T;A	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	114	116	GTA	7;7;7	G;T;A	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	267	269	ACG	13;13;14	A;C;G	13;13;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	330	332	GAA	8;8;8	G;A;A	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	369	371	GCT	9;8;9	G;C;T	9;8;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	387	389	GAT	10;9;9	G;A;T	10;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	474	476	TCA	3;3;3	T;C;A	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	603	605	CAG	6;6;5	C;A;G	6;6;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	741	743	GTT	6;7;7	G;T;T	6;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	905	97.24	evgS.l6.c30.ctg.2	905	8.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	897	899	GAT	1;1;1	G;A;T	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	160	95.62	evgS.l6.c30.ctg.3	210	4.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	139	141	AAT	5;5;5	A;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	774	evgS	3594	160	95.62	evgS.l6.c30.ctg.3	210	4.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	160	162	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	246	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1102	11.1	1	SNP	p	P64A	0	.	.	190	192	CCA	351	353	CCA	19;19;20	C;C;A	19;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	246	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1102	11.1	1	SNP	p	P64S	0	.	.	190	192	CCA	351	353	CCA	19;19;20	C;C;A	19;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	246	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1102	11.1	1	SNP	p	P64H	0	.	.	190	192	CCA	351	353	CCA	19;19;20	C;C;A	19;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	246	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1102	11.1	1	SNP	p	P64L	0	.	.	190	192	CCA	351	353	CCA	19;19;20	C;C;A	19;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	246	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1102	11.1	1	SNP	p	P64R	0	.	.	190	192	CCA	351	353	CCA	19;19;20	C;C;A	19;19;18	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	164	gadE	528	528	100.0	gadE.l15.c30.ctg.1	907	9.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	46	gadW	729	143	97.2	gadW.l15.c4.ctg.1	143	7.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	196	gadX	825	821	97.93	gadX.l15.c4.ctg.1	889	10.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	153	155	TTA	12;12;12	T;T;A	12;12;12	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	196	gadX	825	821	97.93	gadX.l15.c4.ctg.1	889	10.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	231	233	ATT	6;7;7	A;T;T	6;5;5	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	196	gadX	825	821	97.93	gadX.l15.c4.ctg.1	889	10.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	732	734	GGA	12;12;13	G;G;A	12;12;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	196	gadX	825	821	97.93	gadX.l15.c4.ctg.1	889	10.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	738	740	CCG	11;11;11	C;C;G	11;11;11	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2243	2245	GAA	17;17;17	G;A;A	17;16;16	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	S83L	0	.	.	247	249	TCG	458	460	TCG	13;13;12	T;C;G	12;12;12	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	S83I	0	.	.	247	249	TCG	458	460	TCG	13;13;12	T;C;G	12;12;12	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	S83W	0	.	.	247	249	TCG	458	460	TCG	13;13;12	T;C;G	12;12;12	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	D87N	0	.	.	259	261	GAC	470	472	GAC	12;12;13	G;A;C	12;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	D87H	0	.	.	259	261	GAC	470	472	GAC	12;12;13	G;A;C	12;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	D87V	0	.	.	259	261	GAC	470	472	GAC	12;12;13	G;A;C	12;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	D87G	0	.	.	259	261	GAC	470	472	GAC	12;12;13	G;A;C	12;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	646	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3021	11.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	470	472	GAC	12;12;13	G;A;C	12;11;11	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136L	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136E	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136I	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136C	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136H	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136S	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	692	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2817	13.1	1	SNP	p	R136G	0	.	.	406	408	CGC	609	611	CGC	13;12;13	C;G;C	13;12;13	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	152	kdpE	678	678	98.08	kdpE.l6.c30.ctg.1	973	7.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	380	382	CCG	8;8;7	C;C;G	8;8;7	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	152	kdpE	678	678	98.08	kdpE.l6.c30.ctg.1	973	7.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	533	535	GCC	3;3;4	G;C;C	3;3;4	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	316	leuO	945	945	99.26	leuO.l6.c4.ctg.1	1280	13.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	150	152	TCA	8;8;9	T;C;A	8;8;8	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	90	marA	384	384	99.74	marA.l15.c30.ctg.1	618	6.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	0	.	p	.	0	W83L	NONSYN	247	249	TGG	430	432	TTG	6;2;2	T;T,G;G	4;1,1;1	.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	490	492	AGC	4;4;4	A;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	592	594	CAT	4;4;4	C;A;T	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	V45E	0	.	.	133	135	GTG	316	318	GTG	15;15;15	G;T;G	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	I49S	0	.	.	145	147	ATC	328	330	ATC	11;11;10	A;T;C	11;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	A70T	0	.	.	208	210	GCA	391	393	GCA	14;14;14	G;C;A	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R73C	0	.	.	217	219	CGT	400	402	CGT	13;13;13	C;G;T	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R73S	0	.	.	217	219	CGT	400	402	CGT	13;13;13	C;G;T	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R77L	0	.	.	229	231	CGC	412	414	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R77C	0	.	.	229	231	CGC	412	414	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	L78M	0	.	.	232	234	CTG	415	417	CTG	8;8;8	C;T;G	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R94S	0	.	.	280	282	CGC	463	465	CGC	3;3;4	C;G;C	3;3;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	R94H	0	.	.	280	282	CGC	463	465	CGC	3;3;4	C;G;C	3;3;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	80	marR	435	435	97.47	marR.l6.c4.ctg.1	626	6.5	1	SNP	p	V96E	0	.	.	286	288	GTA	469	471	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	688	97.09	mdfA.l15.c4.ctg.1	683	6.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	135	137	CAG	12;11;11	C;A;G	12;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	688	97.09	mdfA.l15.c4.ctg.1	683	6.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	174	176	GCC	7;7;7	G;C;C	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	688	97.09	mdfA.l15.c4.ctg.1	683	6.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	279	281	GCG	3;3;3	G;C;G	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	688	97.09	mdfA.l15.c4.ctg.1	683	6.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	483	485	GTT	3;3;2	G;T;T	3;3;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	688	97.09	mdfA.l15.c4.ctg.1	683	6.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	645	645	C	3	C	3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	161	98.76	mdfA.l15.c4.ctg.2	164	9.2	0	.	p	.	0	V343D	NONSYN	1027	1029	GTT	133	135	GAT	5;5;5	G;A;T	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	151	98.68	mdfA.l15.c4.ctg.3	155	9.2	0	.	p	.	0	L379Q	NONSYN	1135	1137	CTG	53	55	CAG	19;19;18	C;A;G	19;19;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	151	98.68	mdfA.l15.c4.ctg.3	155	9.2	0	.	p	.	0	L391W	NONSYN	1171	1173	TTG	89	91	TGG	8;9;9	T;G;G	8;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	100	96.0	mdfA.l15.c4.ctg.4	100	7.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	3	5	TTC	1;1;1	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	180	mdfA	1233	100	96.0	mdfA.l15.c4.ctg.4	100	7.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	90	92	ATC	6;6;6	A;T;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	218	mdtA	1248	960	97.92	mdtA.l6.c4.ctg.1	1097	7.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	8	10	ATG	6;6;6	A;T;G	6;6;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	218	mdtA	1248	960	97.92	mdtA.l6.c4.ctg.1	1097	7.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	101	103	ACC	3;3;3	A;C;C	3;3;3	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	218	mdtA	1248	164	93.9	mdtA.l6.c4.ctg.2	188	7.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	64	64	G	14	G	14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	218	mdtA	1248	164	93.9	mdtA.l6.c4.ctg.2	188	7.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	121	123	CAG	6;6;5	C;A;G	6;6;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	218	mdtA	1248	113	98.23	mdtA.l6.c4.ctg.3	113	6.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	108	110	ATC	6;5;5	A;T;C	6;5;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1920	1922	ACC	13;13;14	A;C;C	13;13;14	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2313	2315	CAA	6;6;7	C;A;A	6;6;6	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2481	2483	ATT	12;11;11	A;T;T	12;11;11	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2565	2567	GTT	10;10;9	G;T;T	10;10;9	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2673	2675	GAG	11;11;12	G;A;G	11;11;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2901	2903	ATG	8;9;10	A;T;G	8;9;10	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	824	mdtB	3123	3076	99.02	mdtB.l6.c4.ctg.1	3249	13.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3036	3038	GAT	15;15;16	G;A;T	15;15;16	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	698	mdtC	3078	3078	98.67	mdtC.l6.c4.ctg.1	3288	11.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	336	338	ATG	7;6;5	A;T;G	7;6;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	698	mdtC	3078	3078	98.67	mdtC.l6.c4.ctg.1	3288	11.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	822	824	ATC	12;14;15	A;T;C	12;14;14	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	698	mdtC	3078	3078	98.67	mdtC.l6.c4.ctg.1	3288	11.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3138	3140	CAC	1;1;1	C;A;C	1;1;1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	350	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1811	10.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	178	180	GAA	6;6;6	G;A;A	6;6;6	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	350	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1811	10.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	847	849	GCG	7;7;7	G;C;G	6;7;7	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	350	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1811	10.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1189	1191	ATC	7;7;8	A;T;C	7;7;8	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	350	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1811	10.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1492	1494	TTT	15;13;12	T;T;T	15;13;12	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	390	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1566	13.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	878	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3493	13.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1073	1075	ACC	16;16;16	A;C;C	16;15;16	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	878	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3493	13.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2315	2317	GAC	13;13;13	G;A;C	13;13;13	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	306	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1416	9.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	612	614	ATC	12;12;12	A;T;C	12;12;12	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	306	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	411	4.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	105	107	GGA	3;3;4	G;G;A	3;3;4	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	212	mdtH	1209	1194	98.16	mdtH.l15.c4.ctg.1	1223	8.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	385	387	TGT	11;11;11	T;G;T	11;11;11	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	212	mdtH	1209	1194	98.16	mdtH.l15.c4.ctg.1	1223	8.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	955	957	TTG	9;9;9	T;T;G	9;9;9	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	212	mdtH	1209	1194	98.16	mdtH.l15.c4.ctg.1	1223	8.8	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1060	1062	CAG	6;6;6	C;A;G	6;6;6	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	212	mdtH	1209	1194	98.16	mdtH.l15.c4.ctg.1	1223	8.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1165	1167	ACG	5;5;5	A;C;G	5;5;5	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	306	mdtL	1176	1176	98.47	mdtL.l15.c4.ctg.1	1529	10.7	0	.	p	.	0	A185S	NONSYN	553	555	GCC	684	686	TCC	4;4;4	T;C;C	4;4;4	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	513	236	mdtN	1032	423	98.82	mdtN.l6.c4.ctg.1	560	9.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	492	494	ATT	8;8;8	A;T;T	8;8;8	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	513	236	mdtN	1032	620	97.74	mdtN.l6.c4.ctg.2	668	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	167	169	ATG	7;7;6	A;T;G	7;7;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	233	235	ATC	2;2;2	A;T;C	2;2;2	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	482	484	CGC	10;11;11	C;G;C	10;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	848	850	AGC	11;11;12	A;G;C	11;11;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1049	1051	GTG	12;12;11	G;T;G	12;10;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1112	1114	AAC	4;4;4	A;A;C	4;4;4	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1157	1159	GTC	12;12;11	G;T;C	12;11;11	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1187	1189	ATA	15;15;15	A;T;A	15;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1295	1297	TCT	9;9;9	T;C;T	9;9;9	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1682	1684	GCG	7;7;8	G;C;G	7;7;8	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	506	mdtO	2052	2052	98.15	mdtO.l6.c4.ctg.1	2367	11.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1895	1897	ATC	16;16;16	A;T;C	16;16;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	431	433	GCG	10;10;10	G;C;G	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	605	607	ACC	2;2;1	A;C;C	2;2;1	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	677	679	CGC	6;7;7	C;G;C	6;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	794	796	GCT	13;13;13	G;C;T	13;13;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	878	880	AAA	6;6;5	A;A;A	6;6;5	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	896	898	CGA	5;5;4	C;G;A	5;5;4	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1061	1063	GCC	10;9;8	G;C;C	10;9;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1073	1075	GAT	6;7;9	G;A;T	6;7;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	314	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1544	10.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1490	1492	GCT	8;9;9	G;C;T	8;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	766	mfd	3447	3432	99.16	mfd.l15.c4.ctg.1	3592	11.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1294	1296	AAG	15;15;15	A;A;G	15;15;15	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	531	766	mfd	3447	3432	99.16	mfd.l15.c4.ctg.1	3592	11.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2371	2373	CTG	14;14;14	C;T;G	14;14;14	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	42	mgrB	144	141	100.0	mgrB.l15.c30.ctg.2	152	7.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	515	436	msbA	1749	1639	98.72	msbA.l15.c4.ctg.1	1715	12.3	0	.	p	.	0	S278N	NONSYN	832	834	AGC	725	727	AAC	10;10;10	A;A;C	10;10;10	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	515	436	msbA	1749	1639	98.72	msbA.l15.c4.ctg.1	1715	12.3	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1271	1273	ATA	9;9;11	A;T;A	9;9;11	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	515	436	msbA	1749	117	98.29	msbA.l15.c4.ctg.2	262	6.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	300	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	9.9	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1228	1230	GTG	14;15;15	G;T;G	14;15;15	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	300	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	9.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1306	1308	GAT	10;10;10	G;A;T	10;10;10	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	300	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1626	9.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1309	1311	CTG	10;9;9	C;T;G	10;9;9	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	132	134	TGT	5;5;5	T;G;T	5;5;5	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	402	404	ACC	9;10;11	A;C;C	8;9;11	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	612	614	GAC	4;4;4	G;A;C	4;4;4	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	1	SNP	p	R15C	0	.	.	43	45	CGC	96	98	CGC	5;5;4	C;G;C	5;5;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	1	SNP	p	S33R	0	.	.	97	99	AGC	150	152	AGC	7;7;7	A;G;C	7;7;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	1	SNP	p	G131D	0	.	.	391	393	GGC	444	446	GGC	9;9;9	G;G;C	9;9;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	1	SNP	p	R203L	0	.	.	607	609	CGT	660	662	CGT	6;6;6	C;G;T	6;5;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	132	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	825	8.0	1	SNP	p	R203C	0	.	.	607	609	CGT	660	662	CGT	6;6;6	C;G;T	6;5;6	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	342	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1464	12.4	1	SNP	p	G141D	0	.	.	421	423	GGT	616	618	GGT	23;20;20	G;G;T	23;20;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	342	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1464	12.4	1	SNP	p	G141E	0	.	.	421	423	GGT	616	618	GGT	23;20;20	G;G;T	23;20;20	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	342	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1464	12.4	1	SNP	p	R154D	0	.	.	460	462	CGT	655	657	CGT	23;23;22	C;G;T	23;23;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	342	ompF	1089	1089	100.0	ompF.l6.c30.ctg.1	1464	12.4	1	SNP	p	R154A	0	.	.	460	462	CGT	655	657	CGT	23;23;22	C;G;T	23;23;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	654	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2624	13.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1814	1816	TCG	13;12;13	T;C;G	13;12;13	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	654	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2624	13.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2429	2431	AAC	6;6;6	A;A;C	6;6;6	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	654	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2624	13.3	1	SNP	p	A85T	0	.	.	253	255	GCG	443	445	GCG	14;14;13	G;C;G	14;14;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	654	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2624	13.3	1	SNP	p	D111H	0	.	.	331	333	GAT	521	523	GAT	7;7;7	G;A;T	7;6;7	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	654	parC_2	2259	2259	99.29	parC_2.l15.c30.ctg.1	2624	13.3	1	SNP	p	S129P	0	.	.	385	387	TCC	575	577	TCC	16;16;17	T,G;C;C	15,1;16;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	400	parE_1	1893	1747	97.48	parE_1.l15.c4.ctg.1	1818	10.1	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1280	1282	GAT	20;20;20	G;A;T	19;20;20	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	400	parE_1	1893	145	98.62	parE_1.l15.c4.ctg.2	318	6.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	350	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1835	10.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1321	1323	GAT	12;11;11	G;A;T	12;11;11	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	V146F	0	.	.	436	438	GTT	618	620	GTT	15;15;15	G;T;T	15;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1719	1721	CAG	15;15;14	C;A;G	15;15;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1719	1721	CAG	15;15;14	C;A;G	15;15;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1758	1760	CAC	11;10;9	C;A;C	11;10;9	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1767	1769	CGT	9;8;8	C;G;T	9;8;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1767	1769	CGT	9;8;8	C;G;T	9;8;8	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1773	1775	TCC	10;10;10	T;C;C	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1779	1781	CTC	11;11;13	C;T;C	11;11;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1869	1871	ACC	20;20;21	A;C;C	20;20;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1872	1874	CCT	21;21;21	C;C;T	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1166	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4451	14.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2241	2243	CGT	18;18;18	C;G;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	.	n	.	0	A226G	SNP	226	226	A	364	364	G	86	G	86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	.	n	.	0	C719T	SNP	719	719	C	857	857	T	88	T,C	44,44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	A794G	0	.	.	794	794	A	932	932	A	107	A	107	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	A794T	0	.	.	794	794	A	932	932	A	107	A	107	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	G926C	0	.	.	926	926	G	1064	1064	G	104	G,C	102,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	G926A	0	.	.	926	926	G	1064	1064	G	104	G,C	102,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	G926T	0	.	.	926	926	G	1064	1064	G	104	G,C	102,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1657	1657	A	65	A	65	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1657	1657	A	65	A	65	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1657	1657	A	65	A	65	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	C183T	.	183	183	C	321	321	C	81	C,T	56,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	T90C	.	90	90	T	228	228	T	106	T,C	73,30	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	A250T	.	250	250	A	388	388	A	102	A,T	77,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	G474A,T	.	474	474	G	612	612	G	113	G,A,T	78,34,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	A253T	.	253	253	A	391	391	A	105	A,T	80,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1176	1176	C	99	C,T	72,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	C194T	.	194	194	C	332	332	C	70	C,T	59,11	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	G1002A	.	1002	1002	G	1140	1140	G	103	G,A	75,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1144	1144	G	93	G,C	67,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	A79G	.	79	79	A	217	217	A	101	A,G	72,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	T273A	.	273	273	T	411	411	T	110	T,A	88,22	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	3302	rrsB+	1542	1542	99.87	rrsB+.l15.c17.ctg.1	1693	97.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1148	1148	T	97	T,C	68,26	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	160	soxR	465	465	100.0	soxR.l6.c4.ctg.1	740	10.9	1	SNP	p	R20H	0	.	.	58	60	CGC	180	182	CGC	19;19;20	C;G;C	19;19;20	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	160	soxR	465	465	100.0	soxR.l6.c4.ctg.1	740	10.9	1	SNP	p	G121D	0	.	.	361	363	GGT	483	485	GGT	15;16;16	G;G;T	15;16;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	120	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	623	10.0	1	SNP	p	A12S	0	.	.	34	36	GCA	162	164	GCA	14;14;14	G;C;A	14;14;14	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	402	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1905	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
